Effectiveness of catch-up human papillomavirus vaccination on incident cervical neoplasia in a US health-care setting: a population-based case-control study

Effectiveness of catch-up human papillomavirus vaccination on incident cervical neoplasia in a US health-care setting: a population-based case-control study

Background: The population effectiveness of human papillomavirus (HPV) catch-up vaccination, defined in the USA as first vaccination at ages 13–26 years, has not been studied extensively. We aimed to assess the risk of cervical intraepithelial neoplasia (CIN) 2, CIN3, adenocarcinoma in situ, or canc...

Full description

Bibliographic Details
Main Authors: Gregorich, S.E (Author), Huchko, M.J (Author), Kulasingam, S. (Author), Kuppermann, M. (Author), Lam, J.O (Author), Leyden, W.A (Author), Sawaya, G.F (Author), Silverberg, M.J (Author), Smith-McCune, K.K (Author)
Format: Article
Language:English
Published: Elsevier B.V. 2018
Subjects:
adenocarcinoma in situ
adolescent
Adolescent
adult
Adult
age
Age Factors
Article
cancer prevention
cancer risk
case control study
Case-Control Studies
Caucasian
contraceptive behavior
controlled study
drug dose regimen
drug efficacy
female
Female
follow up
groups by age
human
Humans
immunization
Immunization Schedule
major clinical study
observational study
outpatient care
papillomavirus infection
Papillomavirus Infections
Papillomavirus Vaccines
risk assessment
sexually transmitted disease
smoking
treatment outcome
Treatment Outcome
United States
Uterine Cervical Neoplasms
uterine cervix carcinoma
uterine cervix carcinoma in situ
uterine cervix tumor
vaccination
Wart virus vaccine
young adult
Young Adult
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items